Protalix BioTherapeutics, Inc.

PLX · AMEX
Analyze with AI
$1.81+$0.07 (+4.02%)
At close:Dec 16, 2025, 9:00 PM UTC
$1.81+$0.00 (+0%)
After hours:Dec 16, 2025, 11:47 PM UTC
P/E TTM26.6
P/B TTM1.92
P/S TTM2.35
Dividend Yield0%
EPS$0.08
Beta-0.249
Valuation
PEG Ratio-1.67
FCF Yield-8.03%
EV / EBITDA16.12
More On Valuation »
Quality
ROIC8.58%
Gross Margin42.13%
Cash Conv. Ratio-1.86
More On Quality »
Growth
Revenue 3Y CAGR3.88%
FCF Growth399.64%
More On Growth »
Safety
Net Debt / EBITDA-0.63
Interest Coverage8.01
More On Safety »
Efficiency
Inventory Turnover0.84
Cash Conv. Cycle517.68
More On Efficiency »

Protalix BioTherapeutics, Inc. (PLX) stock FAQs

Quick answers sourced from live Financial Modeling Prep fundamentals and AlphaPilot portfolio guidance.

What is Protalix BioTherapeutics, Inc. (PLX) stock price today?

As of Dec 16, 2025, 9:00 PM UTC, Protalix BioTherapeutics, Inc. (PLX) stock is trading at $1.81. The stock price is quoted in USD and refreshes in real-time throughout the trading day. AlphaPilot provides live market data powered by Financial Modeling Prep's institutional-grade API, ensuring you get accurate and up-to-date PLX stock quotes for informed trading decisions.

What is Protalix BioTherapeutics, Inc.'s market capitalization?

Protalix BioTherapeutics, Inc. (PLX) has a market capitalization of approximately $145.6M. Market cap is calculated by multiplying the current share price by the total number of outstanding shares. This valuation metric helps investors compare Protalix BioTherapeutics, Inc.'s size relative to other companies in the USD market. The market cap figure updates automatically as the PLX stock price changes.

What is the 52-week range for Protalix BioTherapeutics, Inc. stock?

Protalix BioTherapeutics, Inc. (PLX) stock has traded in a 52-week range of $1.32 — $3.10. The 52-week range shows the highest and lowest prices at which PLX traded over the past year, helping investors assess price volatility and identify potential support and resistance levels. Comparing the current Protalix BioTherapeutics, Inc. stock price to this range provides context for recent price action.

How much trading volume does Protalix BioTherapeutics, Inc. stock have?

Protalix BioTherapeutics, Inc. (PLX) stock recently traded approximately 314.9K shares. Trading volume indicates market liquidity and investor interest in PLX. Higher volume typically suggests active participation and can signal important price movements or news catalysts affecting Protalix BioTherapeutics, Inc. stock.

Does Protalix BioTherapeutics, Inc. pay dividends to shareholders?

Yes, Protalix BioTherapeutics, Inc. (PLX) currently offers a dividend yield of approximately 0%. Dividend yield is calculated by dividing the company's annual dividend payments by the current stock price, expressed as a percentage. This metric helps income-focused investors evaluate Protalix BioTherapeutics, Inc. stock's potential for generating passive income. Dividend data reflects the trailing twelve months (TTM) of distributions.

What is Protalix BioTherapeutics, Inc.'s intraday price range?

Today, Protalix BioTherapeutics, Inc. (PLX) stock has traded in a range of $1.74 — $1.83. The intraday range represents the lowest and highest prices reached during the current trading session. Monitoring PLX's intraday volatility helps traders identify entry and exit points, while comparing it to the 52-week range provides perspective on short-term versus long-term price movements.

Where does AlphaPilot get Protalix BioTherapeutics, Inc. stock data?

AlphaPilot sources real-time PLX stock quotes, fundamental financial data, and historical price charts for Protalix BioTherapeutics, Inc. from Financial Modeling Prep's institutional-grade API. This enterprise data feed provides live market prices during trading hours, along with comprehensive fundamentals that update after each earnings release, SEC filing, or corporate action. The Protalix BioTherapeutics, Inc. stock summary page combines intraday price movements with key metrics like P/E ratio, market cap, dividend yield, and balance sheet data to give investors a complete view of PLX stock performance.